Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

VIPoma

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Laser Tissue Welding – Distal Pancreatectomy Sealing Study DOTATOC PET/CT for Imaging NET Patients